No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Promising Developments in Mural Oncology Plc's ARTISTRY-7 Trial Boost Buy Rating
H.C. Wainwright Maintains Mural Oncology(MURA.US) With Buy Rating, Maintains Target Price $18
HC Wainwright & Co. Reiterates Buy on Mural Oncology, Maintains $18 Price Target
Analysts Offer Insights on NA Companies: Viking Holdings Ltd (VIK) and Mural Oncology Plc (MURA)
Mural Oncology | 10-K: FY2024 Annual Report
Mural Oncology | 8-K: Mural Oncology Announces Fourth Quarter and Year End 2024 Financial Results and Highlights Upcoming Clinical Milestones